Metabolism and Health Impacts of Dietary Sugars

키워드

참고문헌 (93)

1. Stanhope KL, "Fructose consumption : recent results and their potential implications", Ann N Y Acad Sci, 1190, pp.15~24 (2010)
2. Alexander Bentley R, "U. S. obesity as delayed effect of excess sugar", Econ Hum Biol, 36, pp.100818~ (2020)
3. Walker TB, "Lessons from the war on dietary fat", J Am Coll Nutr, 33, pp.347~351 (2014)
4. Swarup S, "Metabolic syndrome" (2021), StatPearls Publishing
5. Rochlani Y, "Metabolic syndrome : pathophysiology, management, and modulation by natural compounds", Ther Adv Cardiovasc Dis, 11, pp.215~225 (2017)
6. Hirode G, "Trends in the prevalence of metabolic syndrome in the United States, 2011-2016", JAMA, 323, pp.2526~2528 (2020)
7. Lelis DF, "High fructose intake and the route towards cardiometabolic diseases", Life Sci, 259, pp.118235~ (2020)
8. Mueckler M, "The SLC2(GLUT)family of membrane transporters", Mol Aspects Med, 34, pp.121~138 (2013)
9. Holman GD, "Structure, function and regulation of mammalian glucose transporters of the SLC2 family", Pflugers Arch, 472, pp.1155~1175 (2020)
10. Cura AJ, "Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis", Compr Physiol, 2, pp.863~914 (2012)
11. Nijland JG, "Engineering of pentose transport in Saccharomyces cerevisiae for biotechnological applications", Front Bioeng Biotechnol, 7, pp.464~ (2020)
12. Navale AM, "Glucose transporters : physiological and pathological roles", Biophys Rev, 8, pp.5~9 (2016)
13. Sun SZ, "Fructose metabolism in humans-what isotopic tracer studies tell us", Nutr Metab(Lond), 9, pp.89~ (2012)
14. Douard V, "The role of fructose transporters in diseases linked to excessive fructose intake", J Physiol, 591, pp.401~414 (2013)
15. Douard V, "Regulation of the fructose transporter GLUT5 in health and disease", Am J Physiol Endocrinol Metab, 295, pp.E227~E237 (2008)
16. Ferraris RP, "Dietary and developmental regulation of intestinal sugar transport", Biochem J, 360, pp.265~276 (2001)
17. Leturque A, "The role of GLUT2 in dietary sugar handling", J Physiol Biochem, 61, pp.529~537 (2005)
18. Gouyon F, "Simple-sugar meals target GLUT2at enterocyte apical membranes to improve sugar absorption : a study in GLUT2-null mice", J Physiol, 552, pp.823~832 (2003)
19. Chaudhry RM, "Acute enterocyte adaptation to luminal glucose : a posttranslational mechanism for rapid apical recruitment of the transporter GLUT2", J Gastrointest Surg, 16, pp.312~319 (2012)
20. Buchs AE, "Characterization of GLUT5 domains responsible for fructose transport", Endocrinology, 139, pp.827~831 (1998)
21. Barone S, "Slc2a5(Glut5)is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension", J Biol Chem, 284, pp.5056~5066 (2009)
22. Durán JM, "D-mannose transport and metabolism in isolated enterocytes", Glycobiology, 14, pp.495~500 (2004)
23. Silverman M, "Specificity of monosaccharide transport in dog kidney", Am J Physiol, 218, pp.743~750 (1970)
24. Huang CJ, "A robust method for increasing Fc glycan high mannose level of recombinant antibodies", Biotechnol Bioeng, 112, pp.1200~1209 (2015)
25. Alton G, "Direct utilization of mannose for mammalian glycoprotein biosynthesis", Glycobiology, 8, pp.285~295 (1998)
26. Judge A, "Metabolism", Essays Biochem, 64, pp.607~647 (2020)
27. Liu L, "Triose kinase controls the lipogenic potential of fructose and dietary tolerance", Cell Metab, 32, pp.605~618 (2020)
28. Dornas WC, "Health implications of high-fructose intake and current research", Adv Nutr, 6, pp.729~737 (2015)
29. Helsley RN, "Tissue-specific fructose metabolism in obesity and diabetes", Curr Diab Rep, 20, pp.64~ (2020)
30. Merino B, "Intestinal fructose and glucose metabolism in health and disease", Nutrients, 12, pp.94~ (2019)
31. Björkman O, "Role of the kidney in the metabolism of fructose in 60-hour fasted humans", Diabetes, 31, pp.516~520 (1982)
32. Sharma V, "Mannose metabolism : more than meets the eye", Biochem Biophys Res Commun, 453, pp.220~228 (2014)
33. Rorsman P, "Regulation of insulin secretion in human pancreatic islets", Annu Rev Physiol, 75, pp.155~179 (2013)
34. Rorsman P, "The somatostatin-secreting pancreatic δ-cell in health and disease", Nat Rev Endocrinol, 14, pp.404~414 (2018)
35. Quesada I, "Physiology of the pancreatic α-cell and glucagon secretion : role in glucose homeostasis and diabetes", J Endocrinol, 199, pp.5~19 (2008)
36. Marty N, "Brain glucose sensing, counterregulation, and energy homeostasis", Physiology(Bethesda), 22, pp.241~251 (2007)
37. Chen L, "Regulation of glucose and lipid metabolism in health and disease", Sci China Life Sci, 62, pp.1420~1458 (2019)
38. Petersen MC, "Regulation of hepatic glucose metabolism in health and disease", Nat Rev Endocrinol, 13, pp.572~587 (2017)
39. Triplitt CL, "Examining the mechanisms of glucose regulation", Am J Manag Care, 18, pp.S4~S10 (2012)
40. Tan WS, "The role of soluble corn fiber on glycemic and insulin response", Nutrients, 12, pp.961~ (2020)
41. Belobrajdic DP, "High-amylose wheat lowers the postprandial glycemic response to bread in healthy adults : a randomized controlled crossover trial", J Nutr, 149, pp.1335~1345 (2019)
42. Eelderink C, "The structure of wheat bread influences the postprandial metabolic response in healthy men", Food Funct, 6, pp.3236~3248 (2015)
43. Hayward BE, "Structure and alternative splicing of the ketohexokinase gene", Eur J Biochem, 257, pp.85~91 (1998)
44. Bonthron DT, "Molecular basis of essential fructosuria : molecular cloning and mutational analysis of human ketohexokinase(fructokinase)", Hum Mol Genet, 3, pp.1627~1631 (1994)
45. Ishimoto T, "Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice", Proc Natl Acad Sci U S A, 109, pp.4320~4325 (2012)
46. Froesch ER, "Fructose metabolism in adipose tissue", Acta Med Scand Suppl, 542, pp.37~46 (1972)
47. Mirtschink P, "HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease", Nature, 522, pp.444~449 (2015)
48. Jang C, "The small intestine shields the liver from fructose-induced steatosis", Nat Metab, 2, pp.586~593 (2020)
49. Jang C, "The small intestine converts dietary fructose into glucose and organic acids", Cell Metab, 27, pp.351~361 (2018)
50. Zhao S, "Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate", Nature, 579, pp.586~591 (2020)
51. Lambertz J, "Fructose : a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease", Front Immunol, 8, pp.1159~ (2017)
52. Andres-Hernando A, "Deletion of fructokinase in the liver or in the intestine reveals differential effects on sugar-induced metabolic dysfunction", Cell Metab, 32, pp.117~127 (2020)
53. Taylor SR, "Dietary fructose improves intestinal cell survival and nutrient absorption", Nature, 597, pp.263~267 (2021)
54. Tappy L, "Metabolic effects of fructose and the worldwide increase in obesity", Physiol Rev, 90, pp.23~46 (2010)
55. Bizeau ME, "Hepatic adaptations to sucrose and fructose", Metabolism, 54, pp.1189~1201 (2005)
56. Todoric J, "Fructose stimulated de novo lipogenesis is promoted by inflammation", Nat Metab, 2, pp.1034~1045 (2020)
57. Oh JH, "Dietary fructose and microbiotaderived short-chain fatty acids promote bacteriophage production in the gut symbiont Lactobacillus reuteri", Cell Host Microbe, 25, pp.273~284 (2019)
58. Chang PV, "The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition", Proc Natl Acad Sci U S A, 111, pp.2247~2252 (2014)
59. Kelly CJ, "Crosstalk between microbiotaderived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function", Cell Host Microbe, 17, pp.662~671 (2015)
60. Cheng WL, "Sugar fructose triggers gut dysbiosis and metabolic inflammation with cardiac arrhythmogenesis", Biomedicines, 9, pp.728~ (2021)
61. Sharma V, "Mannose efflux from the cells : a potential source of mannose in blood", J Biol Chem, 286, pp.10193~10200 (2011)
62. Ichikawa M, "The metabolic origins of mannose in glycoproteins", J Biol Chem, 289, pp.6751~6761 (2014)
63. Panneerselvam K, "Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts", J Clin Invest, 97, pp.1478~1487 (1996)
64. Schneider A, "Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice", Nat Med, 18, pp.71~73 (2011)
65. Niehues R, "Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy", J Clin Invest, 101, pp.1414~1420 (1998)
66. Harms HK, "Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency", Acta Paediatr, 91, pp.1065~1072 (2002)
67. Sharma V, "Mannose alters gut microbiome, prevents diet-induced obesity, and improves host metabolism", Cell Reports, 24, pp.3087~3098 (2018)
68. Zhang D, "D-mannose induces regulatory T cells and suppresses immunopathology", Nat Med, 23, pp.1036~1045 (2017)
69. Torretta S, "D-mannose suppresses macrophage IL-1β production", Nat Commun, 11, pp.6343~ (2020)
70. Gonzalez PS, "Mannose impairs tumour growth and enhances chemotherapy", Nature, 563, pp.719~723 (2018)
71. Coelho AI, "Galactose metabolism and health", Curr Opin Clin Nutr Metab Care, 18, pp.422~427 (2015)
72. Wilson JM, "IgE, α-Gal and atherosclerosis", Aging(Albany NY), 11, pp.1900~1902 (2019)
73. Azman KF, "D-Galactose-induced accelerated aging model : an overview", Biogerontology, 20, pp.763~782 (2019)
74. Umbayev B, "Galactose-induced skin aging : the role of oxidative stress", Oxid Med Cell Longev, 2020, pp.7145656~ (2020)
75. Parameshwaran K, "D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice", Rejuvenation Res, 13, pp.729~735 (2010)
76. Shwe T, "Role of D-galactose-induced brain aging and its potential used for therapeutic interventions", Exp Gerontol, 101, pp.13~36 (2018)
77. Cui X, "Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice : protective effects of R-α-lipoic acid", J Neurosci Res, 83, pp.1584~1590 (2006)
78. Ali T, "Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE", NF-K B, J Pineal Res, pp.2015, 58[DOI]
79. Bo-Htay C, "Aging induced by D-galactose aggravates cardiac dysfunction via exacerbating mitochondrial dysfunction in obese insulinresistant rats", Geroscience, 42, pp.233~249 (2020)
80. Salkovic-Petrisic M, "Long-term oral galactose treatment prevents cognitive deficits in male Wistar rats treated intracerebroventricularly with streptozotocin", Neuropharmacology, 77, pp.68~80 (2014)
81. Knezovic A, "Glucagon-like peptide-1mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer’s disease", Neuropharmacology, 135, pp.48~62 (2018)
82. 곽미진, "Relative Sweetness and Sensory Characteristics of Bulk and Intense Sweeteners", Food Science and Biotechnology, 21(3), pp.889~894 (2012), 한국식품과학회[DOI]
83. Xiang S, "Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota", Microbiome, 9, pp.62~ (2021)
84. Xiong Y, "Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41", Proc Natl Acad Sci U S A, 101, pp.1045~1050 (2004)
85. Amo K, "Effects of xylitol on metabolic parameters and visceral fat accumulation", J Clin Biochem Nutr, 49, pp.1~7 (2011)
86. Lim E, "D-Xylose suppresses adipogenesis and regulates lipid metabolism genes in high-fat diet-induced obese mice", Nutr Res, 35, pp.626~636 (2015)
87. 김유리, "D-Xylose as a sugar complement regulates blood glucose levels by suppressing phosphoenolpyruvate carboxylase (PEPCK) in streptozotocin-nicotinamide-induced diabetic rats and by enhancing glucose uptake in vitro", Nutrition Research and Practice, 10(1), pp.11~18 (2016), 한국영양학회
88. Seri K, "L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals", Metabolism, 45, pp.1368~1374 (1996)
89. 배윤정, "Coconut-derived D-xylose affects postprandial glucose and insulin responses in healthy individuals", Nutrition Research and Practice, 5(6), pp.533~539 (2011), 한국영양학회
90. Jun YJ, "Beneficial effect of xylose consumption on postprandial hyperglycemia in Korean : a randomized double-blind, crossover design", Trials, 17, pp.139~ (2016)
91. 윤향식, "신규 기능성당 L-아라비노스: 생리활성, 이용, 생산방법", 한국식품과학회지, 35(5), pp.757~763 (2003), 한국식품과학회
92. Wang Y, "L-arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice", Food Funct, 12, pp.1745~1756 (2021)
93. Hao L, "Protective effects of L-arabinose in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats", Food Nutr Res, 59, pp.28886~ (2015)

관련 논문AI추천